InvestorsHub Logo

Horseb4CarT

12/10/22 2:47 PM

#547025 RE: SkyLimit2022 #547007

Don’t know whether the Biden admin is aware yet, however they have a great opportunity to get behind, and of course take some credit for, the potentially broad breakthrough platform of Dcvax and combo treatments across solid tumor cancers -

Can you say Moonshot? I knew you could!

Biden especially has the closest of ties to GBM, which DCVax L immediately is a victory (both personally for Biden I would think, and politically.)

And also imminently the amazingly great promise that DCVax-PD1 is indicating, and which could be in practice very quickly especially with admin support.

Then at the same time the moonshot umbrella can facilitate multiple parallel studies and trials across the most needed cancers or as many as could be pursued.

This could transform, at least for immunotherapy and DCVax in particular, a more serial attack on cancer into a geometrically expanding attack!!!

Maybe too much caffeine today? :-)

dr_lowenstein

12/10/22 3:38 PM

#547050 RE: SkyLimit2022 #547007

These fda approvals for p1 p2 etc. how dies fda do that ? Show us the firm they use